Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Xarelto® on Prevention of Stroke and Non-central Nervous System Systemic Embolism in Patients With Non-valvular Atrial Fibrillation in China: A Non-interventional Study

NCT02784717 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT02784717
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02784717 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Xarelto® on Prevention of Stroke and Non-central Nervous System Systemic Embolism in Patients With Non-valvular Atrial Fibrillation in China: A Non-interventional Study
Lead sponsor
Bayer
Phase
Observational
Overall status
Completed
Start date
May 11, 2016
Completion date
September 24, 2019
Enrollment
3,055 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

stroke